Transcode Therapeutics News

Transcode Therapeutics Reports Increased Losses Amid Funding Challenges

TipRanksNov 15 12:31

Transcode Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 15 05:36 · Announcements

TransCode Therapeutics Urges Shareholders To Approve Potential Reverse Stock Split To Maintain Nasdaq Listing Amidst Capital Raising Needs; Vote Scheduled For November 22

BenzingaNov 12 20:25

TransCode Therapeutics Open Letter to Shareholders

GlobeNewswireNov 12 20:00

Express News | Transcode Therapeutics Announces Nasdaq Extension to Regain Compliance

BreakingsNov 5 20:00

H.C. Wainwright Maintains Transcode Therapeutics(RNAZ.US) With Buy Rating, Maintains Target Price $3

Futu NewsOct 24 18:31 · Ratings

TransCode Therapeutics: Pioneering MicroRNA-Based Cancer Therapy With Promising Clinical Progress

TipRanksOct 24 18:29

Express News | Transcode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 Ttx-Mc138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data

BreakingsOct 23 19:00

TransCode Therapeutics Shares Are Trading Higher After the Company Announced It's Dosed Patients in the First Cohort of Its Phase 1A Dose-escalation Clinical Trial of TTX-MC138.

BenzingaOct 10 22:20

Express News | Transcode Therapeutics Inc - No Significant Safety or Dose Limiting Toxicities Reported

BreakingsOct 10 19:00

12 Health Care Stocks Moving In Thursday's Intraday Session

BenzingaOct 4 00:30

Express News | Transcode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial With First-in-Class Lead Therapeutic Candidate

BreakingsSep 17 19:00

TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial With First-in-Class Lead Therapeutic Candidate

GlobeNewswireSep 17 19:00

TransCode Therapeutics and Michigan State Target Metastatic Breast Cancer in New Study

BenzingaSep 10 19:06

TransCode Therapeutics Announces Publication of Study With Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate's Preclinical Efficacy Against Metastatic Cancer

GlobeNewswireSep 10 19:00

Buy Rating for TransCode Therapeutics Backed by NIH Grant and Promising Treatment Efficacy

TipRanksSep 6 00:05 · Ratings

Express News | Transcode Therapeutics Inc Shares up 3.5% on US Government Grant for Cancer Therapy

BreakingsSep 5 21:32

Express News | Transcode Therapeutics Awarded $2 Million Nih Grant to Support Clinical Evaluation of Lead Candidate

BreakingsSep 5 19:00

TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate

Yahoo FinanceSep 5 19:00

New Research Published In Oncotarget Shows Inhibition Of MiR-10b With MN-anti-miR10b Nanodrug Targets Stem Cell-Like Properties In Metastatic Breast Cancer, Reducing Stemness And Preventing Metastasis In Mouse Models When Combined With Chemotherapy

BenzingaAug 29 02:16